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Abstract 
Unani system of medicine (Unanipathy) originated in Greece, enriched by Persians and Arabs and now 
became an integral part of Alternative medicinal systems of Pakistan and India. Habbe Sara (HS) is a Unani 
medicine prescribed for liver damage and febrile convulsions. The drug was tested for antioxidant activity, 
as there is growing evidence of role of free radicals in disease progression in liver disorders and epilepsy 
and benefits of concomitant antioxidant administration. Currently available antiepileptic drugs either 
exacerbate or decrease free radicals. Habbe Sara was tested for free radical scavenging and metal chelating 
activity. It showed considerable in vitro antioxidant activity in a dose dependent manner.      
Keywords: Unani, Ascorbic acid, Disodium ethylene diamine tetra acetic acid, Free radical scavenging, 
Metal chelation 
 
1. Introduction 
Unani system is one of the traditional alternative medicinal systems of Pakistan and India. Habbe Sara is a 
Unani medicine prescribed for febrile convulsions. The test formulation, Habbe Sara is composed of 
extracts of herb/plants each 100 mg silver coated pill contains: Castoreum (Jund) 33.33 mg, Aloe vera 
(Dried Latex) (Aelwah Zard) 33.33 mg and Boswellia serrata (Kundur) 33.33 mg (Rehman, 1985 and 
Kabeeruddin, 1989).  Epilepsies are common and frequently devastating disorders and current therapy 
involves – limiting sustained repetitive firing of neurons by promoting inactive state of voltage activated 
Na+ channels (carbamazepine, phenytoin, valproate, topiramate, zonisamide), enhancing GABA–mediated 
synaptic inhibition (benzodiazepines, barbiturates, vigabatrin, valproate, tiagabine) and some reduce the 
flow of Ca2+ through T- type Ca2+ channels (valproate, ethosuximide) and liver disorders are treated by 
hepatoprotective agents which have antioxidant activity (Anupama et al., 2009 and McNamara, 2006). 
Recent studies showed the significance of oxidative stress, mitochondrial dysfunction and free 
radicals in liver damage and epilepsy (Sudha, 2001 and Patel, 2002). Oxidative stress is caused by – 
reactive oxygen species (ROS) and reactive nitrogen species (RNS). ROS are either free radicals 
(superoxide anion radical 1O2•, •OH) or non radicals that are oxidizing agents and / or easily convert into 
radicals (HOCl, HOBr, O3, ONOO-, H2O2). Similarly RNS are either free radicals (NO•, NO2•) or non 
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radicals (HNO2, N2O4). These are capable of damaging nucleic acids, lipids, proteins and carbohydrates 
and also can cause DNA damage, cellular damage and neuronal death (Halliwell et al., 1999 and Gulcin et 
al., 2003). Cells contain two types of natural defense systems – enzymes to detoxify (viz., superoxide 
dismutase, catalase and peroxidase) and antioxidants (vitamins C and E, glutathione, ferritin and uric acid). 
Saturation of these defense systems causes oxidative stress (Arzimanoglou et al., 2002). The defense 
mechanisms act by removing oxygen or decreasing local oxygen concentration, removing catalytic metal 
ions, ROS and RNS, quenching or scavenging initiating free radicals, breaking the chain of initiated 
sequence, enhancing endogenous antioxidant defenses by up-regulating expression of genes encoding the 
antioxidant enzymes, repairing oxidative damage caused by radicals, increasing elimination of damaged 
molecules and not repairing excessively damaged molecules in order to minimize introduction of mutation 
(Wood et al., 2006). 
Thus therapies aimed at reducing oxidative stress may ameliorate tissue damage and favorably alter the 
clinical course (Costello and Delanty, 2004).Several Studies showed that the current antiepileptic drugs 
either ameliorate or exacerbate oxidative stress and free radical mediated tissue injury (Liu et al., 1998 and 
Solowiej et al., 2003) 
In the present study we have taken up two in vitro antioxidant models – free radical scavenging activity and 
metal chelating activity, to test the antioxidant potential of Habbe Sara. 
2. Materials and Methods 
2.1. Drug 
The formulation Habbe Sara was obtained as research sample from Madina pharmacy, Satellite Town, 
Sargodha, Pakistan and was triturated, dissolved in methanol and filtered. 
2.2 Chemicals 
DPPH• (1,1-Diphenyl-2-picrylhydrazyl radical) was obtained from Sigma. L-Ascorbic acid (AA), ferrous 
chloride (FeCl2), ferrozine, Disodium ethylene diamine tetra acetate (EDTA) and solvents were of 
analytical grade. 
2.3 Free radical scavenging activity 
The free radical scavenging activity of Habbe Sara was measured employing the method of Blois (Blois, 
1958). To 1ml of different concentrations (1,10,20,30,40,50,60,70,80,90,100 μg/ml) of Habbe Sara, 1ml of 
0.1mM solution of DPPH• in methanol was added and stirred vigorously on vortex mixer. The reaction 
mixture was kept in dark for 30minutes and the absorbance was measured at 517nm using 
UVSpectrophotometer (Shimadzu, Japan). A control containing only DPPH• was taken and different 
concentrations of AA (1-100μg/ml) as standard. All measurements were made in triplicate and their means 
taken. Percentage inhibition was calculated using the formula: 
% Inhibition = (Ao-As)/Ao x 100 
Where Ao and As are absorbencies of control and sample/standard respectively. IC50 values introduced by 
Brand-Williams et al were calculated by plotting % Inhibition vs Concentration (Williams et al., 1995). 
2.4 Metal chelating activity  
The chelation of ferrous ions was estimated by method of Dinis et al (Dinis et al., 1994). To the tubes 
containing 1.7ml of deionized water, 50μl of 0.2mM FeCl2.4H2O and 50μl of different concentrations of 
Habbe Sara (20,40,60,80,100 μg/ml) were added mixed and kept aside for 1min. The reaction was initiated 
by the addition of 0.2ml of 5mM ferrozine, mixed on a vortex mixer and after 10min the absorbance of the 
solutions were measured at 562nm in a UV-Vis Spectrophotometer (Shimadzu, Japan). All tests and 
analyses were made in triplicates. The percentage of inhibition of ferrozine-Fe2+ complex formation was 
calculated as follows 
% Inhibition = (Ao-As)/Ao x 100 
Where Ao and As are absorbencies of control and sample/standard respectively. 
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2.5 Statistical analysis 
Results were presented as mean ± SD. Statistical analysis were performed using Graphpad instat 
software. The values p <0.05 were considered significant after performing Duncan’s multiple range test. 
3. Results and Discussion 
3.1 Free radical scavenging activity 
DPPH• is considered to be a model of lipophilic radicals which initiate lipid auto oxidation. DPPH• is 
characterized as a stable free radical by virtue of delocalization of the spare electron over the molecule as a 
whole so that the molecules do not dimerize, as would be case with other free radicals. The delocalization 
also gives rise to deep violet color, characterized by an absorption band at 517nm. When a solution of 
DPPH• is mixed with a substance that can donate hydrogen atom, it reduces to DPPHH 
(1,1-Diphenyl-2-picrylhydrazine, pale yellow color from the picryl group still present) (Molyneux, 2004). 
Figure 1. Reduction of DPPH• 
The free radical scavenging activity of Habbe Sara was evaluated through its ability to quench the DPPH• 
using ascorbic acid as reference. The results are shown in Table 1. Habbe Sara showed free radical 
scavenging activity and the IC50 values of Habbe Sara and AA were found to be 83 ± 6.6μg/ml and 20.3 ± 
2.3 μg/ml respectively (Fig 3). 
 
Fig3. IC50 (μg/ml) of AA and HS against DPPH free radical 
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Table 1. DPPH• Scavenging activity of AA and HS 
 
Conc. μg/ml 
AA %Inhibition Habbe Sara % Inhibition 
 Mean ±SD Mean ±SD 
0 0.0 0.0 0.0 0.0 
1 8.5 8.9 5.8 3.1 
10 23.6 4.5 14.7 5.2 
20 48.2 5.3 36.2 5.8 
30 65.9 1.5 65.3 4.7 
40 87.2 0.5 80.3 4.6 
50 96.1 0.2 95.2 2.1 
60 96.2 0.1 96.1 2.0 
70 96.8 0.2 95.2 2.1 
80 97.1 0.2 96.9 1.0 
90 97.1 0.1 96.9 0.8 
100 97.2 0.2 98.8 0.8 
p<0.05 Duncan’s multiple range test 
3.2 Metal chelating activity 
Metal chelating activity is claimed as one of the antioxidant mechanisms, since it reduces the concentration 
of bivalent transition metal ions which act as catalysts in lipid peroxidation leading to formation of 
hydroxyl radicals and hydrogen peroxide decomposition reactions via fenton reactions (Halliwell, 1997). 
Ferrozine (Fig 4) quantitatively forms complexes with Fe2+, however in presence of chelating agents, the 
complex formation is disrupted and the dark red color (562nm) of the complex decreases. The color 
reduction allows the estimation of chelating activity of co-existing chelator. Ferrozine 
(3-(2-pyridyl)-5,6-bis(4-phenyl-sulfonic acid)-1,2,4-triazine) Habbe Sara interfered with chelation of Fe2+ 
ions in a dose dependant manner reducing the intensity of the color of Fe2+-ferrozine complex. Results are 
shown in Table 2 and Fig 5. 
 
Fig 4. Structure of ferrozine 
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Table 2. Fe
2+
 Chelating Activity of EDTA and Habbe Sara 
 
Conc. μg/ml 
 
EDTA %Inhibition  Habbe Sara % Inhibition 
Mean ±SD Mean ±SD 
0 0 0 0 0 
20 98.5 0.4 9 0.4 
40 98.4 0.3 32 6.8 
60 98.6 0.2 50 4.7 
80 98.7 0.1 58 2.1 
100 99.1 0.1 68.5 1.6 
p<0.05 Duncan’s multiple range test 
 
Fig 5. Fe2+ Chelating Activity of EDTA and HS 
Concentration for Inhibition 50% of metal chelation by Habbe Sara was found to be 60 ± 6.2 μg/ml and that 
of disodium EDTA was 10.7 ± 0.6 μg/ml Fig 6. 
 
Fig 6. Inhibition of metal chelation by EDTA and HS 
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4. Conclusion 
Unani medicines are used extensively, but lack scientific evidence. Habbe Sara showed considerable 
antiepileptic and antioxidant activity. By its free radical scavenging and metal chelating activity, Habbe 
Sara besides antiepileptic activity, might reduce the free radical generation and quench the radicals already 
formed and inhibit neuronal damage. Further studies are required to determine its mechanism of action and 
toxicities. 
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